Presentations at FutureTox V
Organ-specific Toxicology
May 10-11, 2022 - Chapel Hill, North Carolina, USA
ICCVAM Committee Participation
- Suzanne Fitzpatrick, FDA Center for Food Safety and Applied Nutrition (ICCVAM principal agency representative, FDA) and Donna Mendrick, FDA National Center for Toxicological Research (ICCVAM member, FDA) were members of the conference organizing committee.
- Donna Mendrick, FDA, was a lead discussant for the following plenary sessions:
- New Models for Evaluating Effects of Drugs and Chemicals on the Liver
- New Technologies for Organ Injury for Prediction and Assessment
- Suzanne Fitzpatrick, FDA, Donna Mendrick, FDA, and Acting NICEATM Director Nicole Kleinstreuer (ICCVAM member, NIEHS) led breakout group discussions at the end of the meeting.
NICEATM Poster Presentations
Fit for Purpose Evaluations of In Vitro Assays for IVIVE
Authors: X Chang, S Bell, J Abedini, D Allen, N Kleinstreuer
View Chang et al poster
Integrating Parameter Uncertainty in PBPK Modeling
Authors: D Hines, J Abedini, D Allen, N Kleinstreuer, K Mansouri
View Hines et al poster
Developing In Vitro Assay Annotations to Provide Context and Facilitate Interpretation Toward Toxicological Endpoints
Authors: AL Karmaus, P Ceger, J Rooney, S Bell, D Allen, N Kleinstreuer
View Karmaus et al poster